Wird geladen...
Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators
BACKGROUND: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulations changed to allow community-based prescribing and supply of clozapine for ma...
Gespeichert in:
| Veröffentlicht in: | J Pharm Policy Pract |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685252/ https://ncbi.nlm.nih.gov/pubmed/31406580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-019-0180-3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|